# A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting

> **NCT02181998** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1606 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Full dose tenecteplase
- **DRUG:** Unfractioned heparin
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT02181998
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2002-08
- **Final completion:** —
- **Target enrollment:** 1606 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02181998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02181998, "A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02181998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*